SAREPTA THERAPEUTICS, INC. Operating Leases, Future Minimum Payments Due, Next Twelve Months
SAREPTA THERAPEUTICS, INC. (SRPT) had Operating Leases, Future Minimum Payments Due, Next Twelve Months of $11.39 million as of 2018-12-31, per its 10-K filed 2020-02-26.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent · last filed 2020-02-26
- 2018-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $11.39M; Operating Leases, Future Minimum Payments Due, Next Twelve Months as first filed $11.59M.
- 2017-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $4.95M.
- 2016-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $4.74M.
- 2015-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $4.62M.
| Period end | Operating Leases, Future Minimum Payments Due, Next Twelve Months | Operating Leases, Future Minimum Payments Due, Next Twelve Months as first filed |
|---|---|---|
| 2018-12-31 | $11.39M 10-K · filed 2020-02-26 | $11.59M 10-K · filed 2019-02-28 |
| 2017-12-31 | $4.95M 10-K · filed 2018-03-01 | |
| 2016-12-31 | $4.74M 10-K · filed 2017-02-28 | |
| 2015-12-31 | $4.62M 10-K · filed 2016-02-25 | |
| 2014-12-31 | $4.38M 10-K · filed 2015-02-26 | |
| 2014-09-30 | $4.14M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $4.03M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $3.81M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $3.54M 10-K · filed 2014-03-03 | |
| 2012-12-31 | $1.86M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |